On August 21, 2026, Alexandria Real Estate Equities, Inc. issued $1,000,000,000 in aggregate principal amount of its 7.250% Series A Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2057 through a registered public offering under an effective Form S-3 shelf registration statement. The notes bear interest at 7.250% annually until the First Reset Date on February 15, 2032, after which the rate resets to the five-year U.S. Treasury Rate plus a spread of 2.889%, with a floor of 7.250%. Interest is payable semi-annually in arrears on February 15 and August 15, beginning February 15, 2027. The notes are fully guaranteed by Alexandria Real Estate Equities, L.P., rank junior to senior debt, and mature on February 15, 2057. This real estate investment trust specializes in the acquisition, development, and management of life science and technology properties.

Alexandria Real Estate Equities, Inc. priced a public offering of $1,000,000,000 aggregate principal amount of 7.250% Series A Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2057 on August 12, 2026. The notes were sold at par (100.000%) and bear interest at 7.250% annually through February 15, 2032, resetting thereafter based on the five-year U.S. Treasury Rate plus a spread of 2.889%, subject to a floor of 7.250%. The offering is underwritten by J.P. Morgan Securities LLC and other major banks, with closing expected around August 21, 2026. Proceeds are intended for general corporate purposes, including debt repayment and property acquisitions. Alexandria Real Estate Equities, Inc. operates as a life science real estate investment trust (REIT), specializing in the ownership, operation, and development of collaborative ecosystems in innovation clusters.

Alexandria Real Estate Equities, Inc. reported financial and operating results for the second quarter ended June 30, 2026. The company posted a diluted net loss of $73.7 million, or $(0.43) per share, compared to a loss of $109.6 million in the prior year period. Funds from operations attributable to common stockholders were $296.1 million, or $1.73 per share. Operating properties occupancy stood at 86.9%, rising to 90.9% when including executed leases with future occupancy dates. Total leasing volume surpassed 1.0 million rentable square feet, a 60% increase from the first quarter of 2026. The company maintains significant liquidity of $3.6 billion and targets an annualized net debt to Adjusted EBITDA ratio between 5.6x and 6.2x by year-end. Alexandria Real Estate Equities operates as a real estate investment trust focused on life science properties.

On July 9, 2026, Alexandria Real Estate Equities, Inc. and its Operating Partnership entered into an escrow agreement to lock in terms for a Fourth Amended Credit Agreement. Once effective, the agreement will replace the existing credit facility with a $5 billion unsecured senior revolving credit facility, featuring an accordion option to increase commitments by up to $1 billion. The facility is expected to have a margin of 0.725% over the Floating Rate or Daily RFR and a maturity date of January 22, 2032, with two six-month extension options. Effectiveness is contingent upon satisfying certain conditions by October 1, 2026, including the full payment of obligations under the Third Amended and Restated Credit Agreement. The company operates in the real estate industry, specializing in the ownership and development of life science campuses.

Alexandria Real Estate Equities, Inc. has released its financial and operating results for the first quarter ended March 31, 2026. This report is a key event for investors as it provides the latest data on the company's operational performance and overall financial health.